AI could take 'years' off the drug development process, says Bausch + Lomb CEO Brent Saunders
Bausch + Lomb CEO Brent Saunders joins 'Squawk on the Street' to discuss the impacts of artificial intelligence on healthcare, the company's latest earnings report, and more. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worl…